Emtriva (Excella GmbH)
Welcome to the PulseAid listing for the Emtriva drug offered from Excella GmbH. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Excella GmbH |
| NON-PROPRIETARY NAME: | emtricitabine |
| SUBSTANCE NAME: | EMTRICITABINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2003-07-02 |
| END MARKETING DATE: | 0000-00-00 |
Emtriva HUMAN PRESCRIPTION DRUG Details:
| Item Description | Emtriva from Excella GmbH |
| LABELER NAME: | Excella GmbH |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 2003-07-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 46014-0601_1920b87b-ac14-4b51-ae82-9ccf51f1b00e |
| PRODUCT NDC: | 46014-0601 |
| APPLICATION NUMBER: | NDA021500 |
Other EMTRICITABINE Pharmaceutical Manufacturers / Labelers:
